{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:08:14Z","timestamp":1793257694299,"version":"4.5.0"},"reference-count":148,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,25]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Maternal alloantibodies directed to human platelet antigen 1a (HPA-1a) on fetal platelets can induce fetal-neonatal alloimmune thrombocytopenia (FNAIT), which causes intracranial hemorrhage in 10% to 20% of fetuses\/newborns. Presentation is usually unexpected and identified by neonatal bleeding. This review synthesizes advances in diagnosis, pathophysiology, and management that reshape understanding of anti\u2013HPA-1a\u2013mediated FNAIT. Genomic and serologic testing, together with cell-free fetal DNA for fetal HPA typing, allow accurate identification of at-risk pregnancies. HPA-1bb women who carry DRB3\u221701:01 are at greatest risk of forming clinically significant anti\u2013HPA-1a. Not only anti\u2013HPA-1a levels but also structural features, particularly decreased Fc fucosylation enhancing Fc gamma receptor\u2013mediated effector functions, more accurately determine disease severity. Furthermore, increased Fc galactosylation may contribute by enhancing complement activation. Fab-mediated effects affect platelets, megakaryocytes, trophoblasts, and endothelial cells. Overall, this explains why anti\u2013HPA-1a levels and neonatal platelet counts alone do not reliably predict bleeding, including intracranial hemorrhage. Anti\u2013HPA-1a also induces placental inflammation, increasing risks of fetal growth restriction and long-term neurodevelopmental impairment, for example, autism. Neonatal management involves random donor and matched platelet transfusions, and IV immunoglobulin (IVIG), if needed. Antenatal IVIG, with\/without prednisone administered in an affected pregnancy typically increases fetal platelet counts, with management strategies varying internationally. Blocking neonatal Fc receptor has emerged as an alternative approach to both reduce maternal anti\u2013HPAa-1a levels and inhibit its transplacental transfer. Whether antenatal treatment reduces placental inflammation requires further study. These developments support the importance of identifying predictive biomarkers of fetal risk to guide antenatal management and of preventing affected pregnancies ideally by screening all pregnancies followed by prophylaxis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025032550","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:29:59Z","timestamp":1772648999000},"page":"3144-3167","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Anti\u2013HPA-1a fetal-neonatal alloimmune thrombocytopenia: reframing diagnostics, pathophysiology, and management"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2884-9247","authenticated-orcid":false,"given":"James B.","family":"Bussel","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Weill Cornell School of Medicine, New York NY"},{"name":"2Department of Obstetrics and Gynecology, Weill Cornell School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4092-9525","authenticated-orcid":false,"given":"Jory M.","family":"Hirshman","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Weill Cornell School of Medicine, New York NY"},{"name":"2Department of Obstetrics and Gynecology, Weill Cornell School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-876X","authenticated-orcid":false,"given":"Rick","family":"Kapur","sequence":"additional","affiliation":[{"name":"3Sanquin Blood Supply Foundation, Department Research, Amsterdam, The Netherlands"},{"name":"4Amsterdam University Medical Center location University of Amsterdam, Landsteiner Laboratory, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2026062511214980100_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1423-0410.1959.tb04032.x","article-title":"Serological and genetical studies on a platelet antigen (Zw)","volume":"4","author":"Van Loghem","year":"1959","journal-title":"Vox Sang"},{"issue":"2","key":"2026062511214980100_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pbc.20282","article-title":"Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia","volume":"45","author":"Bussel","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2026062511214980100_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood.V84.6.1851.1851","article-title":"Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings","volume":"84","author":"Hohlfeld","year":"1994","journal-title":"Blood"},{"issue":"8","key":"2026062511214980100_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"issue":"1","key":"2026062511214980100_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12235","article-title":"Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management","volume":"161","author":"Peterson","year":"2013","journal-title":"Br J Haematol"},{"issue":"4","key":"2026062511214980100_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjh.17731","article-title":"Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia","volume":"195","author":"de Vos","year":"2021","journal-title":"Br J Haematol"},{"issue":"55","key":"2026062511214980100_bib130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000415432","article-title":"Allo-immune thrombocytopenias, definition of a group at risk; a prospective study","author":"Reznikoff-Etievant","year":"1988","journal-title":"Curr Stud Hematol Blood Transfus"},{"issue":"2","key":"2026062511214980100_bib131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.1990.tb02567.x","article-title":"Alloimmunization to the PlA1 platelet antigen: results of a prospective study","volume":"74","author":"Blanchette","year":"1990","journal-title":"Br J Haematol"},{"issue":"2","key":"2026062511214980100_bib132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.1995.tb05152.x","article-title":"Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study","volume":"90","author":"Doughty","year":"1995","journal-title":"Br J Haematol"},{"issue":"7","key":"2026062511214980100_bib24","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"issue":"4","key":"2026062511214980100_bib134","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.0042-9007.2003.00363.x","article-title":"Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia","volume":"85","author":"Maslanka","year":"2003","journal-title":"Vox Sang"},{"issue":"5","key":"2026062511214980100_bib135","first-page":"492","article-title":"Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland","volume":"110","author":"Davoren","year":"2003","journal-title":"BJOG"},{"issue":"12","key":"2026062511214980100_bib36","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion"},{"issue":"3","key":"2026062511214980100_bib136","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2026062511214980100_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.12515","article-title":"A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn","volume":"93","author":"Killie","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"2026062511214980100_bib137","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.transci.2012.04.001","article-title":"Foetal\/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies","volume":"47","author":"Husebekk","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"2026062511214980100_bib138","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.5114\/aoms.2016.63600","article-title":"Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a","volume":"14","author":"D\u0119bska","year":"2018","journal-title":"Arch Med Sci"},{"key":"2026062511214980100_bib139","doi-asserted-by":"crossref","first-page":"104168","DOI":"10.1016\/j.jri.2023.104168","article-title":"What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - new insights from a large prospective screening study in Poland","volume":"160","author":"Coucheron","year":"2023","journal-title":"J Reprod Immunol"},{"issue":"12","key":"2026062511214980100_bib50","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/S2352-3026(23)00271-5","article-title":"Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study","volume":"10","author":"de Vos","year":"2023","journal-title":"Lancet Haematol"},{"issue":"7","key":"2026062511214980100_bib133","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2007-994382","article-title":"Screening primiparous women and newborns for fetal\/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group","volume":"13","author":"Durand-Zaleski","year":"1996","journal-title":"Am J Perinatol"},{"issue":"9","key":"2026062511214980100_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1537-2995.1996.36996420760.x","article-title":"Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese","volume":"36","author":"Tanaka","year":"1996","journal-title":"Transfusion"},{"issue":"5","key":"2026062511214980100_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-3148.2006.00687.x","article-title":"Establishment of an HPA-1- to -16-typed platelet donor registry in China","volume":"16","author":"Feng","year":"2006","journal-title":"Transfus Med"},{"issue":"5","key":"2026062511214980100_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000547985","article-title":"Diagnosis and management of fetal and neonatal alloimmune thrombocytopenia: an update 2025","volume":"52","author":"Sachs","year":"2025","journal-title":"Transfus Med Hemother"},{"issue":"6","key":"2026062511214980100_bib10","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/trf.12509","article-title":"A new bead-based human platelet antigen antibodies detection assay versus the monoclonal antibody immobilization of platelet antigens assay","volume":"54","author":"Porcelijn","year":"2014","journal-title":"Transfusion"},{"issue":"1","key":"2026062511214980100_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/trf.13351","article-title":"A bead-based assay in the work-up of suspected platelet alloimmunization","volume":"56","author":"Cooper","year":"2016","journal-title":"Transfusion"},{"issue":"2","key":"2026062511214980100_bib12","first-page":"152","article-title":"In vitro generated megakaryocytes for the detection of human platelet antigen-specific alloantibodies","volume":"52","author":"Uzun","year":"2025","journal-title":"Transfus Med Hemother"},{"issue":"22","key":"2026062511214980100_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood.2019002225","article-title":"Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"issue":"20","key":"2026062511214980100_bib14","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood.2023022893","article-title":"How I use noninvasive prenatal testing for red blood cell and platelet antigens","volume":"145","author":"van 't Oever","year":"2025","journal-title":"Blood"},{"issue":"14","key":"2026062511214980100_bib15","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1182\/bloodadvances.2020002137","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3\u221701:01 on fetal\/neonatal outcome","volume":"4","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2026062511214980100_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"issue":"23","key":"2026062511214980100_bib17","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2026062511214980100_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1537-2995.1989.29289146830.x","article-title":"Testing of maternal sera in pregnancies at risk for neonatal alloimmune thrombocytopenia","volume":"29","author":"McFarland","year":"1989","journal-title":"Transfusion"},{"issue":"4","key":"2026062511214980100_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2141.1994.tb06742.x","article-title":"Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia","volume":"87","author":"Proulx","year":"1994","journal-title":"Br J Haematol"},{"issue":"1","key":"2026062511214980100_bib34","first-page":"27","article-title":"Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test","volume":"68","author":"Dawkins","year":"1995","journal-title":"Vox Sang"},{"issue":"1-2","key":"2026062511214980100_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0301-2115(96)02485-2","article-title":"Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families","volume":"68","author":"Kanhai","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"2026062511214980100_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1471-0528.2000.tb13315.x","article-title":"Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn","volume":"107","author":"Jaegtvik","year":"2000","journal-title":"BJOG"},{"issue":"1","key":"2026062511214980100_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1537-2995.2007.01063.x","article-title":"Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study","volume":"47","author":"Killie","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"2026062511214980100_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1538-7836.2006.01809.x","article-title":"Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia","volume":"4","author":"Bertrand","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026062511214980100_bib37","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1537-2995.2007.01273.x","article-title":"HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"2026062511214980100_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.transci.2008.09.006","article-title":"Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT)","volume":"39","author":"Bessos","year":"2008","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"2026062511214980100_bib29","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2026062511214980100_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/tme.12018","article-title":"Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia","volume":"23","author":"Sainio","year":"2013","journal-title":"Transfus Med"},{"issue":"4","key":"2026062511214980100_bib31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1182\/blood-2014-04-569541","article-title":"Prediction of IVIG treatment efficiency in fetal\/neonatal alloimmune thrombocytopenia","volume":"124","author":"Bertrand","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2026062511214980100_bib92","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/AOG.0b013e31823403f4","article-title":"Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification","volume":"118","author":"Pacheco","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"20","key":"2026062511214980100_bib18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1182\/blood.2022017937","article-title":"Protecting the fetus from FNAIT","volume":"140","author":"Semple","year":"2022","journal-title":"Blood"},{"issue":"8634","key":"2026062511214980100_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 cases of suspected neonatal alloimmune thrombocytopenia","volume":"1","author":"Mueller-Eckhardt","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"2026062511214980100_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/blre.2001.0187","article-title":"Alloimmune thrombocytopenia of the fetus and the newborn","volume":"16","author":"Kaplan","year":"2002","journal-title":"Blood Rev"},{"issue":"5","key":"2026062511214980100_bib21","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"key":"2026062511214980100_bib22","doi-asserted-by":"crossref","first-page":"101038","DOI":"10.1016\/j.blre.2022.101038","article-title":"Fetal and neonatal alloimmune thrombocytopenia: current pathophysiological insights and perspectives for future diagnostics and treatment","volume":"59","author":"Stam","year":"2023","journal-title":"Blood Rev"},{"issue":"4","key":"2026062511214980100_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"13","key":"2026062511214980100_bib72","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.3390\/ijms22136763","article-title":"Placental complement activation in fetal and neonatal alloimmune thrombocytopenia: an observational study","volume":"22","author":"de Vos","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2026062511214980100_bib140","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1160\/TH05-03-0159","article-title":"Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a","volume":"94","author":"Kroll","year":"2005","journal-title":"Thromb Haemost"},{"key":"2026062511214980100_bib141","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2017.12.017","article-title":"Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets","volume":"162","author":"Refsum","year":"2018","journal-title":"Thromb Res"},{"issue":"4","key":"2026062511214980100_bib142","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1160\/TH03-07-0484","article-title":"The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function","volume":"91","author":"Joutsi-Korhonen","year":"2004","journal-title":"Thromb Haemost"},{"issue":"8","key":"2026062511214980100_bib62","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial \u03b1v\u03b23 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2026062511214980100_bib65","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI77820","article-title":"Maternal anti-platelet \u03b23 integrins impair angiogenesis and cause intracranial hemorrhage","volume":"125","author":"Yougbar\u00e9","year":"2015","journal-title":"J Clin Invest"},{"issue":"5","key":"2026062511214980100_bib144","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000515703","article-title":"Maternal anti-HPA-1a antibodies increase endothelial cell apoptosis and permeability","volume":"58","author":"Dardik","year":"2021","journal-title":"J Vasc Res"},{"issue":"3","key":"2026062511214980100_bib145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molimm.2008.10.015","article-title":"HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity","volume":"46","author":"van Gils","year":"2009","journal-title":"Mol Immunol"},{"issue":"1","key":"2026062511214980100_bib146","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12958-017-0245-6","article-title":"Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model","volume":"15","author":"Eksteen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"2026062511214980100_bib147","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-00269-1","article-title":"Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia","volume":"8","author":"Yougbar\u00e9","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"2026062511214980100_bib61","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2014-11-611020","article-title":"Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies","volume":"126","author":"Liu","year":"2015","journal-title":"Blood"},{"issue":"30","key":"2026062511214980100_bib44","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"2026062511214980100_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"MAbs"},{"issue":"6","key":"2026062511214980100_bib48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J Immunol"},{"issue":"10","key":"2026062511214980100_bib59","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3324\/haematol.2021.280493","article-title":"Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets","volume":"107","author":"Van Osch","year":"2022","journal-title":"Haematologica"},{"issue":"11","key":"2026062511214980100_bib52","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2014-05-579110","article-title":"C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia","volume":"125","author":"Kapur","year":"2015","journal-title":"Blood"},{"key":"2026062511214980100_bib148","doi-asserted-by":"crossref","first-page":"594773","DOI":"10.3389\/fimmu.2021.594773","article-title":"C-reactive protein enhances IgG-mediated cellular destruction through IgG-Fc receptors in vitro","volume":"12","author":"Temming","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"2026062511214980100_bib38","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/aogs.70031","article-title":"Improving prediction of fetal\/neonatal intracranial hemorrhage in HPA-1a alloimmunized pregnancies to guide antenatal management: an observational cohort study","volume":"104","author":"Ernstsen","year":"2025","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2026062511214980100_bib39","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1016\/S2352-3026(25)00029-8","article-title":"Rising to the challenge: an international Delphi Consensus study on fetal and neonatal alloimmune thrombocytopenia","volume":"12","author":"Pothof","year":"2025","journal-title":"Lancet Haematol"},{"issue":"11","key":"2026062511214980100_bib40","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4049\/jimmunol.2400447","article-title":"IgG glycosylation: biomarker, functional modulator, and structural component","volume":"213","author":"Radovani","year":"2024","journal-title":"J Immunol"},{"issue":"31","key":"2026062511214980100_bib41","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026062511214980100_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/glycob\/cwn110","article-title":"The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gamma RIIIa binding affinity to IgG glycoforms lacking core fucosylation","volume":"19","author":"Shibata-Koyama","year":"2009","journal-title":"Glycobiology"},{"issue":"11","key":"2026062511214980100_bib43","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2443.2011.01552.x","article-title":"Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans","volume":"16","author":"Mizushima","year":"2011","journal-title":"Genes Cells"},{"issue":"6176","key":"2026062511214980100_bib47","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"issue":"2","key":"2026062511214980100_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"2026062511214980100_bib51","first-page":"1816","article-title":"Altered glycosylation profile of anti-HPA-1a-specific antibodies: insights from a prospective fetal and neonatal alloimmune thrombocytopenia cohort","volume":"111","author":"Oosterhoff","year":"2026","journal-title":"Haematologica"},{"issue":"2","key":"2026062511214980100_bib53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.19009","article-title":"Fetal and neonatal alloimmune thrombocytopenia: no evidence of systemic inflammation as a modulator of disease severity. Could placental inflammation be key?","volume":"203","author":"B\u00f6hm","year":"2023","journal-title":"Br J Haematol"},{"key":"2026062511214980100_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2017.06.003","article-title":"Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-antibody specificity analysis using epitope data","volume":"122","author":"Dahl","year":"2017","journal-title":"J Reprod Immunol"},{"key":"2026062511214980100_bib55","doi-asserted-by":"crossref","first-page":"1652134","DOI":"10.3389\/fimmu.2025.1652134","article-title":"Anti-HLA antibodies bound to monocytes altered antibody-mediated platelet phagocytosis and led to mild thrombocytopenia","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"2026062511214980100_bib56","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/trf.17342","article-title":"HLA antibodies in fetal and neonatal alloimmune thrombocytopenia","volume":"63","author":"Colvin","year":"2023","journal-title":"Transfusion"},{"issue":"4","key":"2026062511214980100_bib57","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/bjh.16419","article-title":"Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia","volume":"189","author":"Sachs","year":"2020","journal-title":"Br J Haematol"},{"issue":"9","key":"2026062511214980100_bib58","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/trf.15944","article-title":"A combined effect of anti-HPA-1a and anti-HLA Class I in pregnancy?","volume":"60","author":"Dahl","year":"2020","journal-title":"Transfusion"},{"issue":"4","key":"2026062511214980100_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-3148.1994.tb00265.x","article-title":"Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies","volume":"4","author":"Murphy","year":"1994","journal-title":"Transfus Med"},{"issue":"18","key":"2026062511214980100_bib63","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.2025029618","article-title":"HPA-1a antibodies in FNAIT do not distinguish \u03b1v\u03b23 from \u03b1IIb\u03b23 and bind inactive integrins more strongly than active integrins","volume":"146","author":"Oosterhoff","year":"2025","journal-title":"Blood"},{"issue":"18","key":"2026062511214980100_bib64","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1182\/blood.2025030524","article-title":"In pursuit of FNAIT biomarkers: \u03b1V\u03b23 specificity falls short","volume":"146","author":"Newman","year":"2025","journal-title":"Blood"},{"key":"2026062511214980100_bib149","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031683","article-title":"Maternal anti-HPA-1a antibodies block \u03b1IIb\u03b23 and \u03b1v\u03b23 integrin activation which correlates with FNAIT disease severity","author":"Stam","year":"14  2026","journal-title":"Blood"},{"issue":"18","key":"2026062511214980100_bib66","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/bloodadvances.2021004371","article-title":"Preclinical evaluation of immunotherapeutic regimens for fetal\/neonatal alloimmune thrombocytopenia","volume":"5","author":"Zhi","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"2026062511214980100_bib67","first-page":"381","article-title":"Human platelet alloantigens","volume":"1","author":"Valentin","year":"1994","journal-title":"Curr Opin Hematol"},{"issue":"suppl 1","key":"2026062511214980100_bib68","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1182\/blood-2025-3019","article-title":"Patient-derived monoclonal anti-HPA-1a can induce platelet activation through Fc\u03b3RIIa in vitro","volume":"146","author":"Oosterhoff","year":"2025","journal-title":"Blood"},{"issue":"10","key":"2026062511214980100_bib69","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1537-2995.2008.01832.x","article-title":"Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy","volume":"48","author":"Kumpel","year":"2008","journal-title":"Transfusion"},{"issue":"3 pt 2","key":"2026062511214980100_bib70","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ajog.2005.06.043","article-title":"Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy","volume":"193","author":"Althaus","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2026062511214980100_bib71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.placenta.2016.10.009","article-title":"Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: a retrospective cohort study of 21 cases","volume":"48","author":"Dubruc","year":"2016","journal-title":"Placenta"},{"key":"2026062511214980100_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.placenta.2024.10.014","article-title":"Placenta-associated biomarkers and pregnancy outcome in HPA-1a alloimmunization: a prospective cohort study","volume":"158","author":"Nedberg","year":"2024","journal-title":"Placenta"},{"issue":"1","key":"2026062511214980100_bib74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0412.2011.01269.x","article-title":"Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys","volume":"91","author":"Tiller","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2026062511214980100_bib75","doi-asserted-by":"crossref","first-page":"e30835","DOI":"10.1002\/pbc.30835","article-title":"Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?","volume":"71","author":"McKelvy","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2026062511214980100_bib77","doi-asserted-by":"crossref","first-page":"637.e1","DOI":"10.1016\/j.ajog.2022.05.063","article-title":"Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia","volume":"227","author":"de Vos","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2026062511214980100_bib78","doi-asserted-by":"crossref","first-page":"113385","DOI":"10.1016\/j.jpeds.2023.02.031","article-title":"Children newly diagnosed with fetal and neonatal alloimmune thrombocytopenia: neurodevelopmental outcome at school age","volume":"258","author":"de Vos","year":"2023","journal-title":"J Pediatr"},{"issue":"6","key":"2026062511214980100_bib76","doi-asserted-by":"crossref","first-page":"656.e1","DOI":"10.1016\/j.ajog.2025.06.052","article-title":"Increased frequency of autism by previous diagnosis and screening in children with fetal-neonatal alloimmune thrombocytopenia with and without an intracranial hemorrhage","volume":"233","author":"McFarland","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"2026062511214980100_bib113","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1182\/bloodadvances.2020002137","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3\u221701:01 on fetal\/neonatal outcome","volume":"4","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2026062511214980100_bib79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jamapediatrics.2014.2645","article-title":"Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay","volume":"169","author":"Walker","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2026062511214980100_bib80","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Moise","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"2026062511214980100_bib81","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1423-0410.2003.00331.x","article-title":"Nomenclature of human platelet antigens","volume":"85","author":"Metcalfe","year":"2003","journal-title":"Vox Sang"},{"key":"2026062511214980100_bib82","unstructured":"Versiti Blood Research Institute\n          . Human Platelet Antigen (HPA) Database. Versiti. Accessed 11 March 2026. https:\/\/www.versiti.org\/products-services-old\/human-platelet-antigen-hpa-database-old."},{"issue":"12","key":"2026062511214980100_bib83","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/j.1537-2995.2011.03208.x","article-title":"Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland","volume":"51","author":"Cremer","year":"2011","journal-title":"Transfusion"},{"issue":"3","key":"2026062511214980100_bib84","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"2026062511214980100_bib85","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1016\/S2352-3026(22)00243-5","article-title":"Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study","volume":"9","author":"de Vos","year":"2022","journal-title":"Lancet Haematol"},{"issue":"9","key":"2026062511214980100_bib86","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2005-06-2235","article-title":"Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)","volume":"107","author":"Kiefel","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2026062511214980100_bib87","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2010.03.011","article-title":"Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus","volume":"203","author":"Bussel","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2026062511214980100_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26690","article-title":"Imaging and management of fetuses and neonates with alloimmune thrombocytopenia","volume":"64","author":"Kovanlikaya","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2026062511214980100_bib89","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ajh.27193","article-title":"Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second?","volume":"99","author":"Knightly","year":"2024","journal-title":"Am J Hematol"},{"issue":"2 pt 1","key":"2026062511214980100_bib90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0002-9378(95)90559-6","article-title":"Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis","volume":"172","author":"Paidas","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2026062511214980100_bib91","doi-asserted-by":"crossref","first-page":"506.e1","DOI":"10.1016\/j.ajog.2022.04.044","article-title":"Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies","volume":"227","author":"Ernstsen","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026062511214980100_bib101","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04408.x","article-title":"European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia","volume":"122","author":"Birchall","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"2026062511214980100_bib95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2026062511214980100_bib96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000380907","article-title":"Low-dose versus standard-dose intravenous immunoglobulin to prevent fetal intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia: a randomized trial","volume":"38","author":"Paridaans","year":"2015","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"2026062511214980100_bib97","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2016.04.033","article-title":"Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia","volume":"215","author":"Lakkaraja","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2026062511214980100_bib117","first-page":"67","article-title":"Antenatal treatment of alloimmune thrombocytopenia","volume":"80","author":"Lynch","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2026062511214980100_bib118","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br J Haematol"},{"issue":"3","key":"2026062511214980100_bib119","first-page":"210","article-title":"Antenatal invasive and noninvasive management of alloimmune thrombocytopenia","volume":"11","author":"Kornfeld","year":"1996","journal-title":"Fetal Diagn Ther"},{"issue":"9","key":"2026062511214980100_bib120","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2003.00188.x","article-title":"Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period","volume":"82","author":"Tiblad","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2026062511214980100_bib121","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajog.2006.06.066","article-title":"Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage","volume":"195","author":"Yinon","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2026062511214980100_bib122","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-0528.2007.01244.x","article-title":"Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective","volume":"114","author":"van den Akker","year":"2007","journal-title":"BJOG"},{"issue":"1","key":"2026062511214980100_bib123","first-page":"66","article-title":"Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin","volume":"13","author":"Van Der Lugt","year":"2015","journal-title":"Blood Transfus"},{"issue":"4","key":"2026062511214980100_bib124","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/14767058.2010.511333","article-title":"Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?","volume":"24","author":"Mechoulan","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2026062511214980100_bib125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/uog.70105","article-title":"Effectiveness of antenatal intravenous immunoglobulin treatment in recurrent fetal and neonatal alloimmune thrombocytopenia","volume":"66","author":"Zloto","year":"2025","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"2026062511214980100_bib126","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00431-006-0389-4","article-title":"Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG","volume":"166","author":"te Pas","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2026062511214980100_bib127","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-3148.1999.00216.x","article-title":"Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia","volume":"9","author":"Sainio","year":"1999","journal-title":"Transfus Med"},{"issue":"4","key":"2026062511214980100_bib128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1423-0410.2010.01367.x","article-title":"Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts","volume":"99","author":"Giers","year":"2010","journal-title":"Vox Sang"},{"issue":"3","key":"2026062511214980100_bib129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mob.2001.116727","article-title":"A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia","volume":"185","author":"Radder","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"2026062511214980100_bib93","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N Engl J Med"},{"issue":"5","key":"2026062511214980100_bib94","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2026062511214980100_bib98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-3148.1994.tb00266.x","article-title":"Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia","volume":"4","author":"Kroll","year":"1994","journal-title":"Transfus Med"},{"issue":"4","key":"2026062511214980100_bib99","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00043426-198624000-00008","article-title":"In utero cerebral hemorrhage in alloimmune thrombocytopenia","volume":"8","author":"Herman","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"1","key":"2026062511214980100_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.blre.2007.09.002","article-title":"Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates","volume":"22","author":"Bussel","year":"2008","journal-title":"Blood Rev"},{"issue":"1","key":"2026062511214980100_bib102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2141.1997.8762507.x","article-title":"Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high-dose intravenous immunoglobulin: a possible mechanism of action","volume":"96","author":"Urbaniak","year":"1997","journal-title":"Br J Haematol"},{"issue":"2","key":"2026062511214980100_bib103","first-page":"493","article-title":"Maternal IVIG in neonatal alloimmune thrombocytopenia","volume":"98","author":"Bussel","year":"1997","journal-title":"Br J Haematol"},{"issue":"17","key":"2026062511214980100_bib104","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1182\/bloodadvances.2020002003","article-title":"Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia","volume":"4","author":"Robak","year":"2020","journal-title":"Blood Adv"},{"issue":"16","key":"2026062511214980100_bib105","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra2312718","article-title":"Neonatal Fc receptor - biology and therapeutics","volume":"392","author":"Bussel","year":"2025","journal-title":"N Engl J Med"},{"issue":"10","key":"2026062511214980100_bib106","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1182\/blood-2006-05-024539","article-title":"FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis","volume":"108","author":"Vidarsson","year":"2006","journal-title":"Blood"},{"key":"2026062511214980100_bib107","unstructured":"A study of nipocalimab in reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT) (FREESIA-1). ClinicalTrials.gov Identifier: NCT06449651. Updated 13 February 2026. Accessed 11 March 2026. https:\/\/clinicaltrials.gov\/study\/NCT06449651."},{"key":"2026062511214980100_bib108","unstructured":"A study of nipocalimab in reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT) (FREESIA-3). ClinicalTrials.gov Identifier: NCT06533098. Updated 13 February 2026. Accessed 11 March 2026. https:\/\/www.clinicaltrials.gov\/study\/NCT06533098."},{"key":"2026062511214980100_bib109","unstructured":"A study of nipocalimab in pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN) (AZALEA). ClinicalTrials.gov Identifier: NCT05912517. Updated 13 February 2026. Accessed 11 March 2026. https:\/\/clinicaltrials.gov\/study\/NCT05912517."},{"issue":"2","key":"2026062511214980100_bib110","doi-asserted-by":"crossref","first-page":"e0034123","DOI":"10.1128\/mbio.00341-23","article-title":"Evidence for the role of a second Fc-binding receptor in placental IgG transfer in nonhuman primates","volume":"14","author":"Rosenberg","year":"2023","journal-title":"mBio"},{"issue":"6","key":"2026062511214980100_bib111","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/bjh.20112","article-title":"Fetal-neonatal alloimmune thrombocytopenia: mothers are affected too","volume":"206","author":"McFarland","year":"2025","journal-title":"Br J Haematol"},{"issue":"4","key":"2026062511214980100_bib112","doi-asserted-by":"crossref","first-page":"18r12527","DOI":"10.4088\/JCP.18r12527","article-title":"The prevalence of anxiety disorders during pregnancy and the postpartum period: a multivariate bayesian meta-analysis","volume":"80","author":"Fawcett","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2026062511214980100_bib114","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"20","key":"2026062511214980100_bib115","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2022015666","article-title":"Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice","volume":"140","author":"Zhi","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2026062511214980100_bib116","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/a-2398-9344","article-title":"A phase 1b PK\/PD study to demonstrate antigen elimination with RLYB212, a monoclonal anti-HPA-1a antibody for FNAIT prevention","volume":"125","author":"Geisen","year":"2025","journal-title":"Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/26\/3144\/2528530\/blood_bld-2025-032550-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/26\/3144\/2528530\/blood_bld-2025-032550-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:22:21Z","timestamp":1782400941000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/26\/3144\/566921\/Anti-HPA-1a-fetal-neonatal-alloimmune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":148,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025032550","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,25]]},"published":{"date-parts":[[2026,6,25]]}}}